245 related articles for article (PubMed ID: 34177816)
1. Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms.
McFadden DG; Sadow PM
Front Endocrinol (Lausanne); 2021; 12():696386. PubMed ID: 34177816
[TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
3. Unraveling Hürthle cell lesions of the thyroid using molecular findings.
Wong KS
Cancer Cytopathol; 2022 Jun; 130(6):405-406. PubMed ID: 35285577
[No Abstract] [Full Text] [Related]
4. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
5. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
[TBL] [Abstract][Full Text] [Related]
6. Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario.
Straccia P; Santeusanio G; Pierconti F; Brunelli C; Fadda G
Appl Immunohistochem Mol Morphol; 2019; 27(10):726-731. PubMed ID: 30358610
[TBL] [Abstract][Full Text] [Related]
7. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
8. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
9. Oncocytic Change in Thyroid Pathology.
Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
Alaedeen DI; Khiyami A; McHenry CR
Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
[TBL] [Abstract][Full Text] [Related]
11. Hurthle cell tumor of the thyroid gland: report of a rare case and review of literature.
Okere PC; Olusina DB; Enyinnah MO
Niger J Clin Pract; 2014; 17(3):375-7. PubMed ID: 24714021
[TBL] [Abstract][Full Text] [Related]
12. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
13. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
Montone KT; Baloch ZW; LiVolsi VA
Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations in Hürthle cell nodules and preoperative cancer risk.
Doerfler WR; Nikitski AV; Morariu EM; Ohori NP; Chiosea SI; Landau MS; Nikiforova MN; Nikiforov YE; Yip L; Manroa P
Endocr Relat Cancer; 2021 Apr; 28(5):301-309. PubMed ID: 33792557
[TBL] [Abstract][Full Text] [Related]
15. Papillary Hürthle cell tumor of thyroid: report of a case with a cytomorphologic approach to diagnosis.
Dziecioł J; Musiatowicz B; Zimnoch L; Kemona A; Sulkowski S
Acta Cytol; 1996; 40(2):311-4. PubMed ID: 8629418
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
17. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience in Hurthle cell tumors].
Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
[TBL] [Abstract][Full Text] [Related]
19. Hürthle cell lesions of the thyroid: Progress made and challenges remaining.
Wong KS; Angell TE; Barletta JA; Krane JF
Cancer Cytopathol; 2021 May; 129(5):347-362. PubMed ID: 33108684
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Oncocytic (Hürthle Cell) Nodules With Longitudinal Nuclear Grooves: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 15 Cases.
Suster D; Mackinnon AC; Suster S
Arch Pathol Lab Med; 2023 Jun; 147(6):684-691. PubMed ID: 36084253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
